Advances in the management of idiopathic pulmonary fibrosis.

F1000 Med Rep

Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, 200 1st Street SW, Rochester, MN 55905, USA.

Published: April 2010

Idiopathic pulmonary fibrosis (IPF) is a common form of interstitial lung disease and usually results in progressive respiratory insufficiency and death. Steady progress has been made in understanding the pathogenesis of IPF and multiple clinical trials are ongoing, but effective therapy remains elusive.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860576PMC
http://dx.doi.org/10.3410/M2-28DOI Listing

Publication Analysis

Top Keywords

idiopathic pulmonary
8
pulmonary fibrosis
8
advances management
4
management idiopathic
4
fibrosis idiopathic
4
fibrosis ipf
4
ipf common
4
common form
4
form interstitial
4
interstitial lung
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!